| Форма представления | Статьи в российских журналах и сборниках |
| Год публикации | 2012 |
| Язык | английский |
|
Зиганшина Лилия Евгеньевна, автор
|
| Библиографическое описание на языке оригинала |
Gamirova R.G. Pharmacoepidemiology of antiepileptic drugs
in children: Comparative analysis of efficacy
and safety / R.M. Shaimardanovaa and L.E. Ziganshinab // International Journal of Risk & Safety in Medicine/ - 2012. - № 24. - C. 179-185 |
| Аннотация |
Pharmacoepidemiology analysis of efficacy and safety of antiepileptics was carried out in children (3 months?18
years old) registered with municipal children?s epilepsy services: 548 children in 2005, 718 ? In 2007 and 32 ? In 2011. We
used remission lasting for 1 year or longer, and 3 years or longer as primary effectiveness outcomes, and total number of people
with adverse effects as a safety outcome. We found no advantages of newer antiepileptics over the older ones in terms of either
efficacy or safety. Long-term follow up (more than 3 years) showed higher treatment response rate in patients with childhood
versus juvenile absence epilepsy.
|
| Ключевые слова |
pharmacoepidemiology of antiepileptics, efficacy, safety |
| Название журнала |
International Journal of Risk & Safety in Medicine
|
| Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку |
https://repository.kpfu.ru/?p_id=127583 |
| Файлы ресурса | |
|
|
Полная запись метаданных  |
| Поле DC |
Значение |
Язык |
| dc.contributor.author |
Зиганшина Лилия Евгеньевна |
ru_RU |
| dc.date.accessioned |
2012-01-01T00:00:00Z |
ru_RU |
| dc.date.available |
2012-01-01T00:00:00Z |
ru_RU |
| dc.date.issued |
2012 |
ru_RU |
| dc.identifier.citation |
Gamirova R.G. Pharmacoepidemiology of antiepileptic drugs
in children: Comparative analysis of efficacy
and safety / R.M. Shaimardanovaa and L.E. Ziganshinab // International Journal of Risk & Safety in Medicine/ - 2012. - № 24. - C. 179-185 |
ru_RU |
| dc.identifier.uri |
https://repository.kpfu.ru/?p_id=127583 |
ru_RU |
| dc.description.abstract |
International Journal of Risk & Safety in Medicine |
ru_RU |
| dc.description.abstract |
Pharmacoepidemiology analysis of efficacy and safety of antiepileptics was carried out in children (3 months?18
years old) registered with municipal children?s epilepsy services: 548 children in 2005, 718 ? In 2007 and 32 ? In 2011. We
used remission lasting for 1 year or longer, and 3 years or longer as primary effectiveness outcomes, and total number of people
with adverse effects as a safety outcome. We found no advantages of newer antiepileptics over the older ones in terms of either
efficacy or safety. Long-term follow up (more than 3 years) showed higher treatment response rate in patients with childhood
versus juvenile absence epilepsy.
|
ru_RU |
| dc.language.iso |
ru |
ru_RU |
| dc.subject |
pharmacoepidemiology of antiepileptics |
ru_RU |
| dc.subject |
efficacy |
ru_RU |
| dc.subject |
safety |
ru_RU |
| dc.title |
Pharmacoepidemiology of antiepileptic drugs
in children: Comparative analysis of efficacy
and safety |
ru_RU |
| dc.type |
Статьи в российских журналах и сборниках |
ru_RU |
|
EN 
中文 
ES 
Карта сайта
